Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.
John
J
Coutsouvelis
Meredith
M
Wiseman
Lisa
L
Hui
Susan
S
Poole
Michael
M
Dooley
Sushrut
S
Patil
Sharon
S
Avery
Andrew
A
Wei
Andrew
A
Spencer
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D005260:Female; D006074:Gout Suppressants / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D015275:Tumor Lysis Syndrome / Q000188:drug therapy*; D014503:Urate Oxidase / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult
D006074:Gout Suppressants; C469709:rasburicase; D014503:Urate Oxidase